Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-18

Clinical Trial Update: Does Nerve Block + Oral Dexamethasone Reduce Recurrence of Headache Within 72 Hrs? [EARLY_Phase 1]

View source ↗

Summary

An early-phase trial (Phase 1) evaluating whether a nerve block plus oral dexamethasone reduces migraine headache recurrence within 72 hours. The study is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Texas Tech University Health Sciences Center, El Paso | Conditions: Migraine | EARLY_Phase 1 | Status: RECRUITING